Chart looking ready.
Fidelity equity summery score 9.1 up from 8.3 yesterday.
Login to see.
eresearch.fidelity.com/eresearch/goto/evaluate/snapshot.jhtml?symbols=VCEL
VCEL new article: Vericel Corp (NASDAQ:VCEL)’s PDUFA Is Drawing Near
streetregister.com/2016/09/28/vericel-corp-nasdaqvcels-pdufa-is-drawing-near/
also: VCEL Vericel to Present at 2016 Cell & Gene Meeting on the Mesa on Wednesday, October 5, 2016 at 5:45pm Pacific time.
finance.yahoo.com/news/vericel-present-2016-cell-gene-120000327.html
also reminder: VCEL - November 14 (Monday) please also mark your calendar: Vericel to Present Data at the American Heart Association's Scientific Sessions 2016 on the Reduction of Ventricular Arrhythmias with Ixmyelocel-T in the ixCELL-DCM Clinical Trial
investors.vcel.com/releasedetail.cfm?ReleaseID=988093
Fidelity equity summery score 9.1 up from 8.3 yesterday.
Login to see.
eresearch.fidelity.com/eresearch/goto/evaluate/snapshot.jhtml?symbols=VCEL
VCEL new article: Vericel Corp (NASDAQ:VCEL)’s PDUFA Is Drawing Near
streetregister.com/2016/09/28/vericel-corp-nasdaqvcels-pdufa-is-drawing-near/
also: VCEL Vericel to Present at 2016 Cell & Gene Meeting on the Mesa on Wednesday, October 5, 2016 at 5:45pm Pacific time.
finance.yahoo.com/news/vericel-present-2016-cell-gene-120000327.html
also reminder: VCEL - November 14 (Monday) please also mark your calendar: Vericel to Present Data at the American Heart Association's Scientific Sessions 2016 on the Reduction of Ventricular Arrhythmias with Ixmyelocel-T in the ixCELL-DCM Clinical Trial
investors.vcel.com/releasedetail.cfm?ReleaseID=988093
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.